![Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines](/docs/US/2018-06-26/US10004735B2/abs.jpg.600x600.jpg)
- 专利标题： Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
-
申请号： US15655270申请日： 2017-07-20
-
公开(公告)号： US10004735B2公开(公告)日： 2018-06-26
- 发明人: Kimberly Elizabeth Fultz , Tam Minh Tran , Shuichan Xu , Weiming Xu
- 申请人： Signal Pharmaceuticals, LLC
- 申请人地址： US CA San Diego
- 专利权人： Signal Pharmaceuticals, LLC
- 当前专利权人： Signal Pharmaceuticals, LLC
- 当前专利权人地址： US CA San Diego
- 代理机构： Jones Day
- 主分类号： A61K31/4985
- IPC分类号： A61K31/4985 ; A61K31/704 ; A61K31/7048 ; A61K31/282 ; A61K31/337 ; A61K31/519 ; A61K31/517 ; A61K31/44 ; A61K31/4184 ; A61K38/14 ; A61K31/69 ; A61K31/501
![Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines](/abs-image/US/2018/06/26/US10004735B2/abs.jpg.150x150.jpg)
摘要：
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount a second active agent to a patient having a cancer.
公开/授权文献
信息查询
IPC分类:
